Randomized Trialhigh evidence
Toxicant Exposures After Switching From Cigarettes to a Pod-Based Electronic Cigarette: A Randomized Clinical Trial.
JAMA network open·May 1, 2026·PMID 42154468
Why it mattersPod-based e-cigarettes with nicotine salt formulations are widely used, but clinical data on their harm reduction potential are limited. This trial provides direct evidence that switching to a 5% nicotine pod device can increase smoking cessation and reduce exposure to certain toxicants, informing patient counseling on e-cigarette use for harm reduction.
The papers that matter, first.
MedLit ranks the medical literature into a specialty feed with concise summaries, evidence-aware triage, and visual takeaways.
§
MedLit · Evidence, Distilled